“ The government may need to focus more on skincare product manufacturing rather than solely on pharmaceuticals given the potential of our industry. ”
There was a growing customer demand for the products which we produce today. I personally have a background in marketing where I worked for a German pharmaceutical company at the time. When we first established the company, we imported therapeutic skincare products from the Philippines, however, given that we have access to raw materials and the capacity to utilise these ingredients, we made the decision to begin producing our own line of goods.
We started retailing Proderma Sukses Mandiri’s products in 2011 and since we started this venture, we have experienced an annual growth of 150%. Due to our ability to offer products of specific benefits, we are therefore able to experience such strong growth. This motivates our company to uphold the value of innovation so as to maintain this growth trajectory. Our vision is to become a company which prioritises on quality and fulfils GMP, Halal, and ISO certifications. In order to realise said goals, we strive to meet the requirements stipulated within these certifications in addition to providing training, emphasising on teamwork, and creating an open corporate culture among a slew of other strategies.
Proderma Sukses Mandiri is one of only a handful of cosmetics manufacturing companies in Indonesia that offers e-commerce services hence demonstrating our readiness to tap into overseas markets. We have brands that specialises in skin therapeutic products in which Cover-3 is our company’s leading brand focusing on sunblock series; we also have the Moisten brand that specialises in soap bars that are hypoallergenic, moisturising, and is trans-epidermal waterless thus making it suitable for babies. The Moisten product line is the result of intensive research with renowned research institutions such as Universitas Gadjah Mada hence making this brand unique. We often work closely with dermatologists in the formula creation as well as manufacture of our products which caters to both adults and babies. I believe that Proderma Sukses Mandiri’s strengths lies in its clinical research-based measure that is formulated specifically for tropical skin. At the moment, our products can be found in clinics, apocatheries, doctor offices, and hospitals. Taking into consideration the immense potential of this market, we are very much looking to expand our market presence in the coming years.
We are in search of new technological capacity to complement the machinery at our company as a means of expanding our production capabilities. In doing so, we hope to be able to make available medical skin care products to the mass market. We understand that there are potential challenges at bay because skin therapeutic products are often categorised under the cosmetics industry although these are different aspects. For decorative makeup, we are serving as the product manufacturer for the Gendis makeup brand and we will look into other opportunities to increase our presence in this segment.
Proderma has been able to incur steadfast growth in part due to the ASEAN Economic Community. As such, this era encourages us to obtain a large share of the domestic market by increasing our production capacity while the regional partnerships help in reducing distribution costs. In Indonesia, we have an upper-hand in the industry because our products are already well-known amongst dermatologists and health organisations thus helping to widen our distribution network.
Through the national infrastructure development projects, we have seen an impact in terms of a reduction in logistics and transportation costs. However, among the aspects which need to be dealt with in detail by the government is moreso related to the banking industry. Based on our experience, there needs to be a better understanding on banking and financing services in addition to building upon the foundations of trust by banking companies to new customers. Moreover, I believe that the government may need to focus more on skincare product manufacturing rather than solely on pharmaceuticals given the immense potential of our industry.
For export markets, we are looking to enter the Asian and the Middle Eastern regions especially because our products are Halal-certified. Moreover, we are also interested in entering the US and European markets for our baby product line because of its hypoallergenic and moisturising benefits. In understanding this globalised world, we remain open to partnering with investors for wide-ranging opportunities be it investment, partnerships, technology transfer or technological advancements. Proderma’s all-encompassing facilities as well as our certifications thus make us an ideal local partner for investors seeking a cosmetics manufacturing company in Indonesia.
We hope that Proderma Sukses Mandiri is able to reach international markets for product distribution in the next few years. Maintaining healthy skin starts at home and Proderma’s understanding of this concept is the driving force behind our innovation plans. By making available a large array of skin therapeutic products which boasts numerous value-added benefits catering to adults and babies, we are confident that Proderma Sukses Mandiri is the ideal choice for all consumers.